ACE inhibitor-mediated angioedema
- 1 January 2020
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 78, 106081
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Prescription patterns of angiotensin‐converting enzyme inhibitors for various indications: A UK population‐based studyBritish Journal of Clinical Pharmacology, 2018
- Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health RecordThe Journal of Allergy and Clinical Immunology: In Practice, 2017
- Meta-Analysis of Randomized Trials on the Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Patients ≥65 Years of AgeThe American Journal of Cardiology, 2016
- Determinants of angiotensin‐converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research DatalinkBritish Journal of Clinical Pharmacology, 2016
- Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance DatabaseJournal of Clinical Immunology, 2015
- National Trends in the Ambulatory Treatment of Hypertension in the United States, 1997-2012PLOS ONE, 2015
- Angioedema deaths in the United States, 1979–2010Annals of Allergy, Asthma & Immunology, 2014
- Adverse drug effects and angioedema hospitalizations in the United States from 2000 to 2009Allergy and Asthma Proceedings, 2013
- Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone SystemArchives of internal medicine (1960), 2012
- Effects of renin-angiotensin system inhibition end-organ protection: Can we do better?Clinical Therapeutics, 2007